Dublin, Jan. 25, 2023 (GLOBE NEWSWIRE) — The “CRISPR Technology: Global Markets” report has been added to ResearchAndMarkets.com’s offering. The current report provides detailed exposure to the CRISPR technology market. This report highlights the current and future market potential of CRISPR technology, along with a detailed analysis of the drivers, restraints, and challenges in the market. The report also covers market projections for 2027, as well as the competitive environment and regulatory scenario. The report details the market share of CRISPR technology on applications and end users. The market is segmented into Biotechnology & Pharmaceutical Companies, Academics & Government Research Institutes, and Contract Research Organizations (CROs) based on end users. The market is categorized as Drug Development, Agriculture, Diagnostics, Clinical therapy, and Others based on Application. The report includes the company profiles of the key players with detailed information about their business segments, financials, product portfolios, and recent developments. The report also discusses the impact of the COVID-19 pandemic on this market. By geography, the market has been segregated into North America, Europe, Asia-Pacific, and the rest of the world. The North American region includes countries such as the US and Canada; Europe includes Germany, UK, France, and the Rest of Europe; Asia-Pacific includes China, India, Japan, and the Rest of Asia-Pacific. For market estimates, data has been provided for 2019 as the historic year, 2021 as the base year, and forecast for 2027. Key Metrics Report AttributeDetailsNo. of Pages131Forecast Period2022 – 2027Estimated Market Value (USD) in 2022$3.3 BillionForecasted Market Value (USD) by 2027$9.2 BillionCompound Annual Growth Rate22.3%Regions CoveredGlobal Reasons for Doing This Study: CRISPR offers lucrative potential for advanced pharmacological research, with impact spanning the entire preclinical drug discovery pipeline. This technology makes gene editing more tractable and precise and speeds up the process of identifying drug targets and generating realistic disease models. High costs associated with the innovation of new drugs are a risk for pharmaceutical companies and may limit the discovery of new therapeutics. New and advanced technologies like CRISPR remove these barriers, expanding the drug exploration process. This report examines end users, applications, and markets in an effort to help companies and investors prioritize product opportunities and strategic movements. The report highlights key industry and market trends and quantifies the main market segments, allowing the reader to better understand the industry’s structure and the changes occurring within it. Favorable government regulations and funding that support the application of CRISPR in various scientific fields across all regions create unique marketopportunities. This report analyzes the trends and the impact on future growth and development opportunities of CRISPR applications in science. Report Includes 17 data tables and 37 additional tables An up-to-date overview and analysis of the global market for CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technologyAnalyses of the global market trends, with historic revenue data for 2019-2021, estimates for 2022 , and projections of compound annual growth rates (CAGRs) through 2027 Highlights of the market potential for CRISPR technology, industry growth drivers, and areas of focus to forecast this market into various segments and sub-segments Estimation of the actual market size and revenue forecast for the global CRISPR technology market in USD million terms, and corresponding market share analysis by application, end user, and regionDiscussion of the major market dynamics, key shifts and regulations, industry specific challenges, and macroeconomic factors affecting the demand for CRISPR technology market over the coming years (2022-2027) Identification of the companies that are best positioned to meet this d emand because of their proprietary technologies, strategic alliances, or other advantagesA look at the recent technical breakthrough on the use of CRISPR-Cas9 genome editing technology, and how it has propelled the rapid growth in genetic engineering and advanced pharmacological researchComparative study on CRISPR with TALE and ZFN nuclease as a gene editing tool and discussion on its higher adaptability over other nucleases Review of the patent filings and research publications for innovations in the CRISPR-Cas9 genome editing technology Insight into recent industry structure for CRISPR-Cas9 genome editing technology, competitive environment, clinical trials, ongoing research activities, and the COVID-19 impact on the marketplace Company profiles of major players within the industry, including CRISPR Therapeutics AGGenScriptLonza Group LtdPerkinElmerThermo Fisher Scientific Inc. Key Topics Covered: Chapter 1 Introduction Chapter 2 Summary and Highlights Chapter 3 Market Overview3.1 Crispr: Genetic Editing3.2 Components of Crispr-Cas Systems3.2.1 Sgrna3.2.2 Cas9 Nucleases3.3 How Crispr-Cas Works?3.4 Advantage of the Crispr -Cas9 System3.5 Popularity of Crispr Genome Editing3.6 Pros of Genetic Editing3.7 Crispr Development Phases3.7.1 Discovery of Crispr3.7.2 Discovery of Cas9 and Pam3.7.3 Hypothesis: Adaptive Immunity3.7.4 Adaptive Immunity3.7.5 Spacer Sequences: Grnas3. 7.6 Crispr Acts on Dna Targets3.7.7 Cas9 Cleaves Target Dna3.7.8 Tracrrna for Cas9 Systems3.7.9 Crispr Systems in Other Species3.7.10 Cas9-Mediated Cleavage3.7.11 Crispr-Cas9: Genome Editing3.8 Market Potential3.9 Regulatory Framework3.9.1 US Regulation and Oversight3.9.2 Nih Guidelines3.9.3 US Fda3.9.4 Regulatory Issues3.9.5 Regulations of Human Germline Edits3.9.6 Global Regulations3.10 Porter’s Five Forces Analysis of the Market for Crispr Technology3.11 Scientific Publications3.12 Patent Anal ysis3.12.1 Overview of Crispr Technology Intellectual Property (Ip) and Licensing Structure3.13 Future of Crispr3.14 Market Drivers3.14.1 Crispr Versus Chronic Disease3.14.2 High Prevalence of Genetic Disorders3.14.3 Government and Private Funding3.14.4 Increasing Applications of Crispr3. 15 Market Retraints3.15.1 Alternative Technologies3.15.2 Off-Target Activity3.16 Market Challenges3.16.1 Patent Issues3.16.2 Risks Associated With Crispr3.16.3 R&D3.16.4 Governmental Policies and Regulations3.16.5 Bioethical Issues Chapter 4 Industry Structure4.1 Commercial Therapeutics4.2 Correcting Genetic Errors4.3 Microbes4.4 Healthier Food Chapter 5 Impact of Covid-19 on the Market for Crispr Technology5.1 Overview Chapter 6 Competitive Landscape6.1 Overview6.2 Competitive Scenario6.3 Beam Therapeutics6.4 Crispr Therapeutics6.5 Editas Medicine6. 6 Intellia Therapeutics6.7 Growth Strategies6.7.1 Licensing and Agreements6.7.2 Collaborations With Big Biopharmaceutical Companies6.7.3 Mergers and Acquisitions sitions Chapter 7 Global Market for Crispr Technology by End-user7.1 Market Overview7.2 Market Share and Forecast7.3 Biotechnology and Pharmaceutical Companies7.4 Academics and Government Research Institutes7.5 Contract Research Organizations Chapter 8 Global Market for Crispr Technology by Application8. 1 Market Share and Forecast8.2 Drug Development8.3 Agriculture8.4 Diagnostics8.4.1 Infectious Diseases8.4.2 Non-Infectious Diseases8.5 Clinical Therapy8.6 Others Chapter 9 Global Market for Crispr Technology by Region9.1 North America9.1.1 US9.1.2 Canada9.2 Europe9.2.1 Germany9.2.2 United Kingdom9.2.3 France9.2.4 Rest of Europe9.3 Asia-Pacific9.3.1 China9.3.2 Japan9.3.3 India9.3.4 Rest of Asia-Pacific9.4 Rest of the World Chapter 10 Company Profiles Caribou BiosciencesCrispr Therapeutics AGDanaher Corp.Editas MedicineGenscriptHera BiolabsIntellia Therapeutics Inc.Lonza Group Ltd.Mammoth Biosciences Inc.New England Biolabs Inc.Origene TechnologiesPerkinelmerPrecision BiosciencesSynthegoT hermo Fisher ScientificToolgen Inc. For more information about this report visit https://www.researchandmarkets.com/r/21d81y About ResearchAndMarkets.com ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Global CRISPR Technology Market